Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Neuroactive ligand-receptor interaction	22/338	4.6227957137953994E-5	0.014238210798489831	0	0	2.603550295857988	25.9884458959608	CHRM2;NPB;CSH2;CSH1;LHB;TACR3;ADM;ADRB1;CCK;GRIN2D;GH2;KISS1;P2RY6;MTNR1B;CHRNE;P2RY2;LEP;PPY;KISS1R;CRH;TAC3;CGA
PPAR signaling pathway	8/74	5.119558108905786E-4	0.07884119487714909	0	0	4.324324324324325	32.76658267461084	APOA2;OLR1;SLC27A6;PPARG;HMGCS2;ANGPTL4;SLC27A2;ACSBG2
Cytokine-cytokine receptor interaction	17/294	0.0012418507247588487	0.12749667440857512	0	0	2.312925170068027	15.476135015739851	CNTFR;CSF3R;GDF15;CSH2;CSH1;IL27;LIFR;CSF2RB;INHBA;GDF6;BMP7;BMP5;GH2;LEP;CCR7;IL36RN;INHA
Ovarian steroidogenesis	6/49	0.00133183876322073	0.10255158476799621	0	0	4.897959183673469	32.4303416954645	CYP11A1;HSD17B1;LHB;HSD3B1;CGA;CYP19A1
PI3K-Akt signaling pathway	19/354	0.0015768903824504908	0.09713644755895023	0	0	2.1468926553672314	13.852396518451298	CHRM2;ANGPT4;CSF3R;FLT1;ANGPT2;CSH2;HGF;CSH1;AREG;PGF;GNGT1;NTF4;GH2;TCL1B;COL2A1;CCNE1;COL9A3;COL6A6;FGFR3
Synaptic vesicle cycle	6/78	0.013370780182839728	0.6863667160524395	0	0	3.076923076923077	13.275949342551398	SLC6A11;SLC6A2;SLC6A4;SLC18A3;ATP6V1B1;ATP6V1C2
Ras signaling pathway	12/232	0.01418773731308582	0.6242604417757761	0	0	2.068965517241379	8.804228807517664	GNGT1;NTF4;PLA2G2F;ANGPT4;FLT1;ANGPT2;HGF;RASA1;PLA2G5;FOXO4;FGFR3;PGF
Steroid hormone biosynthesis	5/60	0.016937312232839237	0.6520865209643106	0	0	3.333333333333333	13.594120887625653	HSD11B2;CYP11A1;HSD17B1;HSD3B1;CYP19A1
Proximal tubule bicarbonate reclamation	3/23	0.01896828932905573	0.6491370125943516	0	0	5.217391304347825	20.686887009392155	ATP1A4;SLC38A3;SLC4A4
JAK-STAT signaling pathway	9/162	0.020868631238546903	0.6427538421472446	0	0	2.222222222222222	8.598906989252805	GH2;CNTFR;CSF3R;CSH2;CSH1;LEP;LIFR;CSF2RB;IL22RA2
Protein digestion and absorption	6/90	0.025316242186923396	0.7088547812338551	0	0	2.6666666666666665	9.803490948157773	SLC6A19;COL2A1;ATP1A4;COL6A6;COL9A3;KCNN4
Fatty acid biosynthesis	2/13	0.040550197611673826	1.0	0	0	6.153846153846154	19.724397693220933	OLAH;ACSBG2
Transcriptional misregulation in cancer	9/186	0.04463746134335518	1.0	0	0	1.9354838709677418	6.017771287886537	CEBPA;MYCN;FLT1;TLX3;HMGA2;PPARG;MPO;ETV4;GADD45G
ECM-receptor interaction	5/82	0.05456121322238969	1.0	0	0	2.4390243902439024	7.093736656618068	GP9;COL2A1;SDC1;COL6A6;COL9A3
Signaling pathways regulating pluripotency of stem cells	7/139	0.06030005976817401	1.0	0	0	2.014388489208633	5.657253320427078	WNT3A;HAND1;WNT7A;LIFR;INHBA;FGFR3;DUSP9
Aldosterone-regulated sodium reabsorption	3/37	0.06453588403923348	1.0	0	0	3.2432432432432434	8.888217950878486	HSD11B2;SCNN1B;ATP1A4
MAPK signaling pathway	12/295	0.0681473085280815	1.0	0	0	1.6271186440677965	4.3705767294446325	NTF4;DUSP5;ANGPT4;FLT1;ANGPT2;HGF;RASA1;AREG;DUSP9;FGFR3;PGF;GADD45G
Cell adhesion molecules (CAMs)	7/145	0.07210684548524798	1.0	0	0	1.9310344827586206	5.0778604314948605	CLDN6;CD274;CLDN19;SDC1;L1CAM;HLA-G;NECTIN3
TGF-beta signaling pathway	5/90	0.07506739964971518	1.0	0	0	2.222222222222222	5.754153126676802	INHBA;PITX2;GDF6;BMP7;BMP5
Glycine, serine and threonine metabolism	3/40	0.07776165816733924	1.0	0	0	2.9999999999999996	7.6623203846665575	GLDC;PHGDH;BPGM
Glycosaminoglycan degradation	2/19	0.08063617099611983	1.0	0	0	4.2105263157894735	10.601296667256518	HYAL4;SPAM1
Pancreatic secretion	5/98	0.09918802730486051	1.0	0	0	2.0408163265306123	4.71579176421747	PLA2G2F;ATP1A4;CCK;PLA2G5;SLC4A4
ABC transporters	3/45	0.10215828081331627	1.0	0	0	2.6666666666666665	6.0832850553957645	ABCC2;ABCA12;ABCG2
Bile secretion	4/72	0.10589336254947611	1.0	0	0	2.222222222222222	4.989606010945918	ABCC2;ATP1A4;SLC4A4;ABCG2
Hippo signaling pathway	7/160	0.10718169922556198	1.0	0	0	1.7499999999999998	3.90815208192248	WNT3A;WNT7A;GDF6;PRKCZ;BMP7;AREG;BMP5
Ether lipid metabolism	3/47	0.11266904115423244	1.0	0	0	2.553191489361702	5.57438450312141	PLA2G2F;GDPD1;PLA2G5
Arginine and proline metabolism	3/49	0.12357090514220292	1.0	0	0	2.4489795918367343	5.120669772142008	NOS2;CKMT1A;CKMT1B
alpha-Linolenic acid metabolism	2/25	0.12848911332067864	1.0	0	0	3.1999999999999997	6.566115518322446	PLA2G2F;PLA2G5
Cholesterol metabolism	3/50	0.12916025190606503	1.0	0	0	2.4	4.912083318606716	APOA2;ANGPTL4;LRP2
Cardiac muscle contraction	4/78	0.13123847658671212	1.0	0	0	2.051282051282051	4.165618828306458	MYL4;TNNC1;TNNT2;ATP1A4
Mineral absorption	3/51	0.13483744322316818	1.0	0	0	2.352941176470588	4.714553765545066	SLC6A19;TRPV6;ATP1A4
Collecting duct acid secretion	2/27	0.1456305058632748	1.0	0	0	2.962962962962963	5.708689324070283	ATP6V1C2;ATP6V1B1
Glycosaminoglycan biosynthesis	3/53	0.14644202157094957	1.0	0	0	2.2641509433962264	4.349718534458366	HS3ST3B1;HS3ST3A1;HS6ST2
Phototransduction	2/28	0.15436955442437558	1.0	0	0	2.8571428571428568	5.338302420588211	GNGT1;GUCA1A
Linoleic acid metabolism	2/29	0.16320629383915272	1.0	0	0	2.758620689655172	5.000662819323756	PLA2G2F;PLA2G5
Phagosome	6/152	0.1814837820990341	1.0	0	0	1.5789473684210524	2.694614185414532	NCF1;OLR1;MPO;HLA-G;ATP6V1C2;ATP6V1B1
Salivary secretion	4/90	0.18828953531711135	1.0	0	0	1.7777777777777777	2.968487856688808	TRPV6;ATP1A4;ADRB1;KCNN4
Cushing syndrome	6/155	0.19279598910173565	1.0	0	0	1.5483870967741935	2.548835149062689	CCNE1;CYP11A1;WNT3A;HSD3B1;CRH;WNT7A
Small cell lung cancer	4/93	0.2036425912242253	1.0	0	0	1.7204301075268817	2.737873248162342	NOS2;CCNE1;BIRC7;GADD45G
Wnt signaling pathway	6/158	0.20436847453628693	1.0	0	0	1.5189873417721518	2.4118946836174078	PORCN;WNT3A;RSPO2;WNT7A;NOTUM;RSPO4
Human papillomavirus infection	11/330	0.2057641407180759	1.0	0	0	1.3333333333333333	2.1080329521556336	COL2A1;CCNE1;WNT3A;WNT7A;COL9A3;COL6A6;HLA-G;PRKCZ;HES2;ATP6V1C2;ATP6V1B1
Arachidonic acid metabolism	3/63	0.20860938631238252	1.0	0	0	1.9047619047619047	2.985317601379297	PLA2G2F;PLA2G5;PTGES
Basal cell carcinoma	3/63	0.20860938631238252	1.0	0	0	1.9047619047619047	2.985317601379297	WNT3A;WNT7A;GADD45G
Synthesis and degradation of ketone bodies	1/10	0.22371474296156477	1.0	0	0	4.0	5.989534030397172	HMGCS2
Glycerophospholipid metabolism	4/97	0.22465400248636988	1.0	0	0	1.6494845360824741	2.4630001271451514	PLA2G2F;PHOSPHO1;CHAT;PLA2G5
Focal adhesion	7/199	0.23148950997896622	1.0	0	0	1.4070351758793969	2.0588030227614693	MYLPF;COL2A1;FLT1;HGF;COL9A3;COL6A6;PGF
Thyroid cancer	2/37	0.2362702199007159	1.0	0	0	2.1621621621621623	3.1195224419228023	PPARG;GADD45G
HIF-1 signaling pathway	4/100	0.24076340791661854	1.0	0	0	1.5999999999999999	2.2783048601180695	ANGPT4;FLT1;ANGPT2;NOS2
Epithelial cell signaling in Helicobacter pylori infection	3/68	0.2416025942539262	1.0	0	0	1.7647058823529411	2.5066960150114252	IGSF5;ATP6V1B1;ATP6V1C2
Taurine and hypotaurine metabolism	1/11	0.2431315551769016	1.0	0	0	3.6363636363636362	5.142373101111616	CDO1
Rap1 signaling pathway	7/206	0.25773585549622413	1.0	0	0	1.3592233009708736	1.8428621827124072	ANGPT4;FLT1;ANGPT2;HGF;PRKCZ;FGFR3;PGF
Fat digestion and absorption	2/41	0.2735343283108339	1.0	0	0	1.951219512195122	2.529420780778097	PLA2G2F;PLA2G5
cAMP signaling pathway	7/212	0.2808834715337439	1.0	0	0	1.320754716981132	1.6771146630101066	CHRM2;HCAR2;HCAR3;ATP1A4;ADRB1;CGA;GRIN2D
Thyroid hormone synthesis	3/74	0.28218271785894006	1.0	0	0	1.6216216216216217	2.051676457611424	ATP1A4;LRP2;CGA
Alcoholism	6/180	0.2955585415752978	1.0	0	0	1.3333333333333333	1.6251844686924417	HIST1H2AM;GNGT1;CRH;FOSB;HIST1H2BG;GRIN2D
Adrenergic signaling in cardiomyocytes	5/145	0.2971368734639982	1.0	0	0	1.379310344827586	1.6738791626560299	MYL4;TNNC1;TNNT2;ATP1A4;ADRB1
Axon guidance	6/181	0.2999028666848604	1.0	0	0	1.3259668508287292	1.5968574158723403	SEMA7A;SEMA6A;RASA1;L1CAM;PRKCZ;BMP7
Cholinergic synapse	4/112	0.30733899532659725	1.0	0	0	1.4285714285714284	1.6854341732739702	CHRM2;GNGT1;CHAT;SLC18A3
Leukocyte transendothelial migration	4/112	0.30733899532659725	1.0	0	0	1.4285714285714284	1.6854341732739702	CLDN6;MYLPF;NCF1;CLDN19
Thiamine metabolism	1/15	0.3160709178495968	1.0	0	0	2.6666666666666665	3.0714364453326795	ALPL
Complement and coagulation cascades	3/79	0.3164279982103083	1.0	0	0	1.5189873417721518	1.747837301901023	C8G;SERPINB2;F5
Gastric cancer	5/149	0.316701376398177	1.0	0	0	1.3422818791946307	1.5433503078978634	CCNE1;WNT3A;HGF;WNT7A;GADD45G
Thyroid hormone signaling pathway	4/116	0.32999523901017713	1.0	0	0	1.379310344827586	1.5292097267138929	ATP1A4;DIO3;GATA4;MED12L
Calcium signaling pathway	6/188	0.3306142969143183	1.0	0	0	1.276595744680851	1.4129398074579596	CHRM2;NOS2;TNNC1;TACR3;ADRB1;GRIN2D
mTOR signaling pathway	5/152	0.33147910049577933	1.0	0	0	1.3157894736842104	1.4528822586911272	SLC7A5;WNT3A;WNT7A;ATP6V1C2;ATP6V1B1
Cocaine addiction	2/49	0.3474929610282407	1.0	0	0	1.6326530612244896	1.7257320330061812	FOSB;GRIN2D
Malaria	2/49	0.3474929610282407	1.0	0	0	1.6326530612244896	1.7257320330061812	HGF;SDC1
Pathways in cancer	15/530	0.3485098415073424	1.0	0	0	1.1320754716981132	1.1933080862954062	CEBPA;CSF3R;NOS2;WNT3A;HGF;WNT7A;CSF2RB;PGF;GADD45G;GNGT1;GSTA3;CCNE1;PPARG;BIRC7;FGFR3
Vibrio cholerae infection	2/50	0.3565901556321914	1.0	0	0	1.5999999999999999	1.6498690882006875	ATP6V1B1;ATP6V1C2
Insulin secretion	3/86	0.36442414082249097	1.0	0	0	1.3953488372093021	1.4085165595114748	ATP1A4;CCK;KCNN4
Autoimmune thyroid disease	2/53	0.38359202335177106	1.0	0	0	1.5094339622641508	1.4463029892393837	CGA;HLA-G
GABAergic synapse	3/89	0.38485531890079877	1.0	0	0	1.348314606741573	1.2874891825427501	GNGT1;SLC6A11;SLC38A3
Dilated cardiomyopathy (DCM)	3/91	0.39839258143942596	1.0	0	0	1.3186813186813187	1.2136053287868656	TNNC1;TNNT2;ADRB1
Rheumatoid arthritis	3/91	0.39839258143942596	1.0	0	0	1.3186813186813187	1.2136053287868656	FLT1;ATP6V1B1;ATP6V1C2
Regulation of lipolysis in adipocytes	2/55	0.40132045183103177	1.0	0	0	1.4545454545454544	1.3279927840918175	ADRB1;CGA
Hepatocellular carcinoma	5/168	0.4108018106583153	1.0	0	0	1.1904761904761902	1.0591004682118168	WNT3A;GSTA3;HGF;WNT7A;GADD45G
IL-17 signaling pathway	3/93	0.41184736294433893	1.0	0	0	1.2903225806451613	1.1446483568607568	FOSB;S100A9;MAPK4
Arginine biosynthesis	1/21	0.41253720829731133	1.0	0	0	1.9047619047619047	1.6865311911285241	NOS2
Tight junction	5/170	0.4206761550467687	1.0	0	0	1.176470588235294	1.0186964343820846	CLDN6;IGSF5;CLDN19;GATA4;PRKCZ
Terpenoid backbone biosynthesis	1/22	0.42723918724304594	1.0	0	0	1.8181818181818181	1.5462023001914358	HMGCS2
Circadian entrainment	3/97	0.4384603644337263	1.0	0	0	1.2371134020618557	1.0199825075033913	GNGT1;MTNR1B;GRIN2D
Aldosterone synthesis and secretion	3/98	0.4450435426086273	1.0	0	0	1.2244897959183672	0.9913263098498469	CYP11A1;HSD3B1;ATP1A4
Vitamin digestion and absorption	1/24	0.455550643812525	1.0	0	0	1.6666666666666665	1.310413975931712	SLC19A3
Fluid shear stress and atherosclerosis	4/139	0.4596056772594075	1.0	0	0	1.1510791366906474	0.8948332437112545	NCF1;GSTA3;SDC1;PRKCZ
Apoptosis	4/143	0.48143836004449936	1.0	0	0	1.1188811188811187	0.8178764447117186	SPTA1;CSF2RB;BIRC7;GADD45G
Folate biosynthesis	1/26	0.4824653272482855	1.0	0	0	1.5384615384615385	1.1213018790930922	ALPL
Central carbon metabolism in cancer	2/65	0.48595425402499	1.0	0	0	1.2307692307692308	0.8881732763477085	SLC7A5;FGFR3
Cortisol synthesis and secretion	2/65	0.48595425402499	1.0	0	0	1.2307692307692308	0.8881732763477085	CYP11A1;HSD3B1
Acute myeloid leukemia	2/66	0.49400617659427287	1.0	0	0	1.2121212121212122	0.8547966771455834	CEBPA;MPO
Parathyroid hormone synthesis, secretion and action	3/106	0.49650661716240135	1.0	0	0	1.1320754716981132	0.79263222788784	GCM1;MMP15;GATA3
Butanoate metabolism	1/28	0.5080520173426427	1.0	0	0	1.4285714285714284	0.9673877718600257	HMGCS2
Insulin resistance	3/108	0.5089992912119659	1.0	0	0	1.111111111111111	0.7503429499371738	SLC27A6;SLC27A2;PRKCZ
Amphetamine addiction	2/68	0.5098678748711668	1.0	0	0	1.176470588235294	0.7924748890682	FOSB;GRIN2D
Adipocytokine signaling pathway	2/69	0.5176757123539347	1.0	0	0	1.1594202898550725	0.7633695892092621	LEP;ACSBG2
Prolactin signaling pathway	2/70	0.5254004137091046	1.0	0	0	1.1428571428571428	0.7355367020726886	LHB;CGA
Glyoxylate and dicarboxylate metabolism	1/30	0.5323761135569396	1.0	0	0	1.3333333333333333	0.8405400787509358	GLDC
Adherens junction	2/72	0.5405975770602098	1.0	0	0	1.111111111111111	0.6834223634393684	NECTIN4;NECTIN3
Melanoma	2/72	0.5405975770602098	1.0	0	0	1.111111111111111	0.6834223634393684	HGF;GADD45G
p53 signaling pathway	2/72	0.5405975770602098	1.0	0	0	1.111111111111111	0.6834223634393684	CCNE1;GADD45G
Asthma	1/31	0.5440842429149877	1.0	0	0	1.2903225806451613	0.7853563687947012	PRG2
Glutamatergic synapse	3/114	0.5454686522317513	1.0	0	0	1.0526315789473684	0.6380104647156472	GNGT1;SLC38A3;GRIN2D
Leishmaniasis	2/74	0.5554545611303542	1.0	0	0	1.0810810810810811	0.635641590695438	NCF1;NOS2
Fructose and mannose metabolism	1/33	0.5666300836000462	1.0	0	0	1.2121212121212122	0.6885437552033686	PFKFB4
Proteoglycans in cancer	5/201	0.5670425168236146	1.0	0	0	0.9950248756218906	0.564498499986165	WNT3A;HGF;GPC3;SDC1;WNT7A
Cellular senescence	4/160	0.5697792723914314	1.0	0	0	1.0	0.5625062345694026	CCNE1;GATA4;HLA-G;GADD45G
Antigen processing and presentation	2/77	0.5770948361053473	1.0	0	0	1.0389610389610389	0.571167444479923	IFI30;HLA-G
AMPK signaling pathway	3/120	0.5803125850880102	1.0	0	0	1.0	0.5441883808106572	PFKFB4;LEP;PPARG
Prion diseases	1/35	0.5880631079793313	1.0	0	0	1.1428571428571428	0.6067668689681428	C8G
Oocyte meiosis	3/125	0.608029043614279	1.0	0	0	0.96	0.4776313238922669	SPDYE11;CCNE1;SPDYC
Peroxisome	2/83	0.6180333278447322	1.0	0	0	0.963855421686747	0.4638196572792209	NOS2;SLC27A2
Allograft rejection	1/38	0.6182452955593541	1.0	0	0	1.0526315789473684	0.5061789283103968	HLA-G
Osteoclast differentiation	3/127	0.6187688494897862	1.0	0	0	0.9448818897637795	0.45356551345641555	NCF1;FOSB;PPARG
MicroRNAs in cancer	7/299	0.6225065007058422	1.0	0	0	0.9364548494983277	0.44388072970942444	TRIM71;CCNE1;WNT3A;IGF2BP1;HMGA2;FGFR3;TP63
Hypertrophic cardiomyopathy (HCM)	2/85	0.6309855429295065	1.0	0	0	0.9411764705882353	0.433385720533733	TNNC1;TNNT2
Relaxin signaling pathway	3/130	0.6345009758696687	1.0	0	0	0.9230769230769231	0.4199228804448141	GNGT1;NOS2;PRKCZ
Nicotine addiction	1/40	0.6371302636481142	1.0	0	0	1.0	0.4507811487933908	GRIN2D
Colorectal cancer	2/86	0.6373322377682995	1.0	0	0	0.9302325581395349	0.4190364586262058	AREG;GADD45G
FoxO signaling pathway	3/132	0.6447354146223417	1.0	0	0	0.9090909090909091	0.399013869302999	FOXO6;FOXO4;GADD45G
Vascular smooth muscle contraction	3/132	0.6447354146223417	1.0	0	0	0.9090909090909091	0.399013869302999	PLA2G2F;ADM;PLA2G5
Bladder cancer	1/41	0.6462201541186453	1.0	0	0	0.975609756097561	0.42596589015410175	FGFR3
Graft-versus-host disease	1/41	0.6462201541186453	1.0	0	0	0.975609756097561	0.42596589015410175	HLA-G
Systemic lupus erythematosus	3/133	0.649776187680017	1.0	0	0	0.9022556390977443	0.38898703942792145	HIST1H2AM;C8G;HIST1H2BG
Tryptophan metabolism	1/42	0.6550827855909762	1.0	0	0	0.9523809523809523	0.4028511058268805	KMO
Type I diabetes mellitus	1/43	0.6637238288168202	1.0	0	0	0.9302325581395349	0.38129221998251456	HLA-G
Apelin signaling pathway	3/137	0.6694281778392484	1.0	0	0	0.8759124087591241	0.35153115058518086	MYL4;GNGT1;NOS2
Carbohydrate digestion and absorption	1/44	0.6721488131969349	1.0	0	0	0.9090909090909091	0.3611595588775441	ATP1A4
Fatty acid degradation	1/44	0.6721488131969349	1.0	0	0	0.9090909090909091	0.3611595588775441	ACSBG2
GnRH signaling pathway	2/93	0.6793739096257446	1.0	0	0	0.8602150537634409	0.33254505468787643	LHB;CGA
Glycosphingolipid biosynthesis	1/45	0.6803631304766049	1.0	0	0	0.8888888888888888	0.3423365403917318	ST3GAL4
Type II diabetes mellitus	1/46	0.688372038071095	1.0	0	0	0.8695652173913043	0.32471811668930733	PRKCZ
Amoebiasis	2/96	0.6961381393825469	1.0	0	0	0.8333333333333333	0.30183930184762386	C8G;NOS2
Cysteine and methionine metabolism	1/47	0.69618066242957	1.0	0	0	0.8510638297872339	0.30820942968045956	CDO1
Hedgehog signaling pathway	1/47	0.69618066242957	1.0	0	0	0.8510638297872339	0.30820942968045956	LRP2
Sphingolipid metabolism	1/47	0.69618066242957	1.0	0	0	0.8510638297872339	0.30820942968045956	ACER2
Hematopoietic cell lineage	2/97	0.7015629289067601	1.0	0	0	0.8247422680412371	0.29232550701224613	GP9;CSF3R
Chemokine signaling pathway	4/190	0.7028199133421791	1.0	0	0	0.8421052631578947	0.29697228528513436	GNGT1;NCF1;CCR7;PRKCZ
Endocrine and other factor-regulated calcium reabsorption	1/48	0.7037940023867141	1.0	0	0	0.8333333333333333	0.29272464657414204	ATP1A4
Valine, leucine and isoleucine degradation	1/48	0.7037940023867141	1.0	0	0	0.8333333333333333	0.29272464657414204	HMGCS2
Progesterone-mediated oocyte maturation	2/99	0.712171216084855	1.0	0	0	0.8080808080808081	0.27429246420172493	SPDYE11;SPDYC
Breast cancer	3/147	0.714987466611623	1.0	0	0	0.8163265306122448	0.2738696046173723	WNT3A;WNT7A;GADD45G
N-Glycan biosynthesis	1/50	0.7184542048692922	1.0	0	0	0.7999999999999999	0.26452265010260456	MAN1C1
Melanogenesis	2/101	0.7224620897819041	1.0	0	0	0.792079207920792	0.2574972920889452	WNT3A;WNT7A
Amyotrophic lateral sclerosis (ALS)	1/51	0.7255104548045064	1.0	0	0	0.7843137254901961	0.25167042845488546	GRIN2D
Drug metabolism	2/108	0.7560607182937743	1.0	0	0	0.7407407407407407	0.20713599320317938	GSTA3;MPO
Glutathione metabolism	1/56	0.758230644178816	1.0	0	0	0.7142857142857142	0.19769118550302078	GSTA3
Endometrial cancer	1/58	0.770201320910123	1.0	0	0	0.689655172413793	0.18007127074521875	GADD45G
Viral myocarditis	1/59	0.7759629585959883	1.0	0	0	0.6779661016949152	0.1719664364110286	HLA-G
Serotonergic synapse	2/113	0.7778595415712045	1.0	0	0	0.7079646017699115	0.17784729835672625	GNGT1;SLC6A4
Toxoplasmosis	2/113	0.7778595415712045	1.0	0	0	0.7079646017699115	0.17784729835672625	NOS2;BIRC7
Long-term depression	1/60	0.7815804178020295	1.0	0	0	0.6666666666666666	0.1642914883710904	CRH
cGMP-PKG signaling pathway	3/166	0.7879517398264984	1.0	0	0	0.7228915662650601	0.17227838665644046	ATP1A4;GATA4;ADRB1
Sphingolipid signaling pathway	2/119	0.8017528596829252	1.0	0	0	0.6722689075630252	0.14854109150517988	ACER2;PRKCZ
Inflammatory bowel disease (IBD)	1/65	0.8076279713191508	1.0	0	0	0.6153846153846154	0.13147923570947304	GATA3
Non-small cell lung cancer	1/66	0.8124529129968876	1.0	0	0	0.6060606060606061	0.12587716344981695	GADD45G
Lysosome	2/123	0.8163893540594057	1.0	0	0	0.6504065040650406	0.13194399234802529	GM2A;CTSE
Long-term potentiation	1/67	0.8171570734698834	1.0	0	0	0.5970149253731343	0.12055160967876961	GRIN2D
Retinol metabolism	1/67	0.8171570734698834	1.0	0	0	0.5970149253731343	0.12055160967876961	DHRS9
Cell cycle	2/124	0.8198943491236538	1.0	0	0	0.6451612903225806	0.12811599326250314	CCNE1;GADD45G
Platelet activation	2/124	0.8198943491236538	1.0	0	0	0.6451612903225806	0.12811599326250314	GP9;PRKCZ
Glycolysis / Gluconeogenesis	1/68	0.8217434703815468	1.0	0	0	0.588235294117647	0.11548647791811906	BPGM
Renal cell carcinoma	1/69	0.8262150460248844	1.0	0	0	0.5797101449275363	0.11066677859030163	HGF
Renin secretion	1/69	0.8262150460248844	1.0	0	0	0.5797101449275363	0.11066677859030163	ADRB1
Arrhythmogenic right ventricular cardiomyopathy (ARVC)	1/72	0.8389691786747109	1.0	0	0	0.5555555555555555	0.0975451716537232	DSC2
Inositol phosphate metabolism	1/74	0.8469485510129866	1.0	0	0	0.5405405405405406	0.08979206961117422	ISYNA1
Metabolism of xenobiotics by cytochrome P450	1/74	0.8469485510129866	1.0	0	0	0.5405405405405406	0.08979206961117422	GSTA3
Kaposi sarcoma-associated herpesvirus infection	3/186	0.8473181915644505	1.0	0	0	0.6451612903225806	0.10688966836691462	GNGT1;ANGPT2;HLA-G
Oxidative phosphorylation	2/133	0.8488334569866297	1.0	0	0	0.6015037593984962	0.09858181994056327	ATP6V1C2;ATP6V1B1
Gastric acid secretion	1/75	0.8507890041924216	1.0	0	0	0.5333333333333333	0.08618193057063522	ATP1A4
Glioma	1/75	0.8507890041924216	1.0	0	0	0.5333333333333333	0.08618193057063522	GADD45G
Pancreatic cancer	1/75	0.8507890041924216	1.0	0	0	0.5333333333333333	0.08618193057063522	GADD45G
Chronic myeloid leukemia	1/76	0.8545332771182171	1.0	0	0	0.5263157894736842	0.08273675463408255	GADD45G
Pertussis	1/76	0.8545332771182171	1.0	0	0	0.5263157894736842	0.08273675463408255	NOS2
Ubiquitin mediated proteolysis	2/137	0.8602852133033936	1.0	0	0	0.583941605839416	0.08787813216937412	BIRC7;RHOBTB1
Endocytosis	4/244	0.8624040155882754	1.0	0	0	0.6557377049180327	0.09706978527466388	SH3GL3;HLA-G;PRKCZ;FGFR3
Chemical carcinogenesis	1/82	0.8751096392159449	1.0	0	0	0.4878048780487805	0.0650761456161355	GSTA3
Taste transduction	1/83	0.8782447070953916	1.0	0	0	0.4819277108433735	0.06256868168843485	SCNN1B
Epstein-Barr virus infection	3/201	0.8818404296234015	1.0	0	0	0.5970149253731343	0.07507113918653993	CCNE1;HLA-G;GADD45G
Viral carcinogenesis	3/201	0.8818404296234015	1.0	0	0	0.5970149253731343	0.07507113918653993	CCNE1;HIST1H2BG;HLA-G
ErbB signaling pathway	1/85	0.8842811683327172	1.0	0	0	0.47058823529411764	0.057873036795879476	AREG
Salmonella infection	1/86	0.8871864408298141	1.0	0	0	0.46511627906976744	0.055674477287034875	NOS2
Non-alcoholic fatty liver disease (NAFLD)	2/149	0.8900380625870292	1.0	0	0	0.5369127516778524	0.06254553031877225	CEBPA;LEP
Gap junction	1/88	0.8927804067909452	1.0	0	0	0.45454545454545453	0.051552106088443475	ADRB1
Fc gamma R-mediated phagocytosis	1/91	0.9006565431609593	1.0	0	0	0.43956043956043955	0.045991775475609106	NCF1
Morphine addiction	1/91	0.9006565431609593	1.0	0	0	0.43956043956043955	0.045991775475609106	GNGT1
Hepatitis C	2/155	0.9026055871684786	1.0	0	0	0.5161290322580645	0.05288753627142147	CLDN6;CLDN19
Th1 and Th2 cell differentiation	1/92	0.9031514339465523	1.0	0	0	0.43478260869565216	0.04428914725560576	GATA3
Regulation of actin cytoskeleton	3/214	0.9059548785390545	1.0	0	0	0.5607476635514018	0.0553826787568548	MYLPF;CHRM2;FGFR3
Human T-cell leukemia virus 1 infection	3/219	0.913979444701632	1.0	0	0	0.547945205479452	0.049286135433643886	MSX2;CCNE1;HLA-G
Prostate cancer	1/97	0.9147185646131074	1.0	0	0	0.41237113402061853	0.03675828481515323	CCNE1
Choline metabolism in cancer	1/99	0.9189496039479084	1.0	0	0	0.40404040404040403	0.03415110951678137	SLC44A5
Protein processing in endoplasmic reticulum	2/165	0.9206162754068306	1.0	0	0	0.4848484848484848	0.040102772666927876	DERL3;MAN1C1
AGE-RAGE signaling pathway in diabetic complications	1/100	0.9209858941252744	1.0	0	0	0.39999999999999997	0.03292422346760427	PRKCZ
Inflammatory mediator regulation of TRP channels	1/100	0.9209858941252744	1.0	0	0	0.39999999999999997	0.03292422346760427	P2RY2
Longevity regulating pathway	1/102	0.924906569443872	1.0	0	0	0.39215686274509803	0.030612765716779206	PPARG
Chagas disease (American trypanosomiasis)	1/103	0.9267934783334831	1.0	0	0	0.38834951456310673	0.029524086681869306	NOS2
Th17 cell differentiation	1/107	0.933879588462055	1.0	0	0	0.3738317757009345	0.025572997884261654	GATA3
Neurotrophin signaling pathway	1/119	0.9512875582335184	1.0	0	0	0.3361344537815126	0.016786180690548515	NTF4
Dopaminergic synapse	1/131	0.9641189452154209	1.0	0	0	0.30534351145038163	0.011157436589384392	GNGT1
Natural killer cell mediated cytotoxicity	1/131	0.9641189452154209	1.0	0	0	0.30534351145038163	0.011157436589384392	HLA-G
Estrogen signaling pathway	1/137	0.9692072533500224	1.0	0	0	0.291970802919708	0.009131914223382517	KRT14
Insulin signaling pathway	1/137	0.9692072533500224	1.0	0	0	0.291970802919708	0.009131914223382517	PRKCZ
Measles	1/138	0.9699823237314814	1.0	0	0	0.2898550724637681	0.008834037857386757	CCNE1
Human immunodeficiency virus 1 infection	2/212	0.9705507907542545	1.0	0	0	0.3773584905660377	0.01127982759123312	GNGT1;HLA-G
Retrograde endocannabinoid signaling	1/148	0.9767387045916868	1.0	0	0	0.2702702702702703	0.006361110646377103	GNGT1
Human cytomegalovirus infection	2/225	0.9777788032670429	1.0	0	0	0.3555555555555555	0.007989975842406837	GNGT1;HLA-G
Necroptosis	1/162	0.9837256304401564	1.0	0	0	0.24691358024691357	0.0040514201639341345	HIST1H2AM
Hepatitis B	1/163	0.9841357497024394	1.0	0	0	0.24539877300613497	0.0039242783878290135	CCNE1
Alzheimer disease	1/171	0.9870662610586052	1.0	0	0	0.23391812865497075	0.003045171462935469	GRIN2D
NOD-like receptor signaling pathway	1/178	0.9891834443322864	1.0	0	0	0.2247191011235955	0.0024439280665151425	CARD17
Tuberculosis	1/179	0.989456221524802	1.0	0	0	0.22346368715083798	0.0023686609933518603	NOS2
Huntington disease	1/193	0.9926269421435171	1.0	0	0	0.20725388601036268	0.0015337561026800678	PPARG
Thermogenesis	1/231	0.9972102350012009	1.0	0	0	0.17316017316017315	4.837512806465966E-4	PPARG
Herpes simplex virus 1 infection	2/492	0.9999500731124927	1.0	0	0	0.16260162601626016	8.118395755414895E-6	HLA-G;POU2F3
Olfactory transduction	1/444	0.9999850165890991	1.0	0	0	0.09009009009009009	1.34986695074912E-6	OR2B6
